XERS Q1 2022 Earnings — Xeris Biopharma Holdings, Inc. Revenue & Financial Results | Market Cap Arena

XERSXeris Biopharma Holdings, Inc.

$960M

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$22M+169.3% YoY

Gross Profit

$16M71.6% margin

Operating Income

-$29M-131.7% margin

Net Income

-$34M-152.7% margin

EPS (Diluted)

$-0.25

QoQ Revenue Growth

+1.9%

Cash Flow

Operating Cash Flow

-$48M

Free Cash Flow

-$48M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$338M

Total Liabilities

$241M

Stockholders' Equity

$96M

Cash & Equivalents

$104M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$22M	$8M	+169.3%
Gross Profit	$16M	$6M	+148.1%
Operating Income	-$29M	-$17M	-73.7%
Net Income	-$34M	-$18M	-83.1%